496 related articles for article (PubMed ID: 20720243)
1. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
2. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
3. Hospital charges associated with "never events": comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty.
Daniels AH; Kawaguchi S; Contag AG; Rastegar F; Waagmeester G; Anderson PA; Arthur M; Hart RA
J Neurosurg Spine; 2016 Aug; 25(2):165-9. PubMed ID: 26989978
[TBL] [Abstract][Full Text] [Related]
4. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.
Ollendorf DA; Vera-Llonch M; Oster G
Am J Health Syst Pharm; 2002 Sep; 59(18):1750-4. PubMed ID: 12298113
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Curr Med Res Opin; 2011 Feb; 27(2):423-9. PubMed ID: 21192759
[TBL] [Abstract][Full Text] [Related]
6. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
7. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].
Gómez-Cerezo JF; Gómez-Arrayás I; Suárez-Fernández C; Betegón-Nicolás L; de Salas-Cansado M; Rubio-Terrés C
Rev Esp Cir Ortop Traumatol; 2012; 56(6):459-70. PubMed ID: 23594943
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
Mahmoudi M; Sobieraj DM
Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
[TBL] [Abstract][Full Text] [Related]
11. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
14. Effect of post-discharge venous thromboembolism on hospital quality comparisons following hip and knee arthroplasty.
Kester BS; Merkow RP; Ju MH; Peabody TD; Bentrem DJ; Ko CY; Bilimoria KY
J Bone Joint Surg Am; 2014 Sep; 96(17):1476-84. PubMed ID: 25187587
[TBL] [Abstract][Full Text] [Related]
15. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice.
Pedersen AB; Mehnert F; Sorensen HT; Emmeluth C; Overgaard S; Johnsen SP
Bone Joint J; 2014 Apr; 96-B(4):479-85. PubMed ID: 24692614
[TBL] [Abstract][Full Text] [Related]
16. A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.
Kotirum S; Chongmelaxme B; Chaiyakunapruk N
J Thromb Thrombolysis; 2017 Feb; 43(2):252-262. PubMed ID: 27704332
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
[TBL] [Abstract][Full Text] [Related]
18. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
19. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
[TBL] [Abstract][Full Text] [Related]
20. Improving outcomes in patients at risk for venous thromboembolism following total knee and total hip replacement: implications for managed care.
Navarro RP; Barr JE; Faubus K; Sabharwal AD; Stern E; Unger K
Am J Manag Care; 2011 Jul; 17 Suppl 9():S251-8. PubMed ID: 21819165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
